Pharma Research Products Co., Ltd ingeniso iyonke, umvuzo wengeniso kunye nentshukumo yotshintsho kwi Laphumelela yaseMzantsi Korea namhlanje
Ingeniso yenethiwekhi Pharma Research Products Co., Ltd ngoku 34 537 958 090 ₩. Ulwazi malunga nerhafu yengeniso ithathwa kwimithombo evulekileyo. Ingeniso yeNet ye Pharma Research Products Co., Ltd namhlanje ifikelele kwi 12 252 962 630 ₩. Izinto eziguquliweyo ze Pharma Research Products Co., Ltd ingeniso yonke yenyuka. Utshintsho lwalukhona 2 150 544 280 ₩. Ishedyuli yengxelo yemali ye Pharma Research Products Co., Ltd yanamhlanje. Ishedyuli yezemali ye-Pharma Research Products Co., Ltd iqulathe iitshathi ezintathu zezimpawu eziphambili zeenkampani: ii-asethi zizonke, ingeniso iyonke, umvuzo wengeniso. Itshathi yengxelo yemali ibonisa amaxabiso avela 31/12/2018 ukuya 31/03/2021.
|
|
Umhla weNgxelo
|
Ingeniso yonke
Imali engenayo ibalwa ngokuphindaphinda ubuninzi beempahla ezithengiswa ngentengo yempahla.
kwaye
Utshintsho (%)
Ukuthelekiswa kwengxelo yonyaka ngekota ngekota yonyaka odlulileyo.
|
Imali engenayo
Imali engenayo yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo.
kwaye
Utshintsho (%)
Ukuthelekiswa kwengxelo yonyaka ngekota ngekota yonyaka odlulileyo.
|
|
31/03/2021 |
34 537 958 090 ₩ |
+68.84 % ↑ |
12 252 962 630 ₩ |
+138.63 % ↑ |
|
31/12/2020 |
31 247 332 300 ₩ |
+80.32 % ↑ |
10 102 418 350 ₩ |
+50.25 % ↑ |
|
30/09/2020 |
29 126 534 690 ₩ |
+48.67 % ↑ |
7 711 393 710 ₩ |
+102.02 % ↑ |
|
30/06/2020 |
27 696 829 190 ₩ |
+38.2 % ↑ |
10 085 914 720 ₩ |
+197.98 % ↑ |
|
30/09/2019 |
19 590 990 990 ₩ |
-
|
3 817 122 310 ₩ |
-
|
|
30/06/2019 |
20 041 012 160 ₩ |
-
|
3 384 805 010 ₩ |
-
|
|
31/03/2019 |
20 455 978 460 ₩ |
-
|
5 134 684 080 ₩ |
-
|
|
31/12/2018 |
17 328 467 060 ₩ |
-
|
6 723 610 190 ₩ |
-
|
|
|
Bonisa:
|
|
Ukuze
|
|
|
|
Umbiko wezezimali Pharma Research Products Co., Ltd, ishedyuli
Imihla yokugqibela ka Pharma Research Products Co., Ltd ezikhoyo kwi-intanethi: 31/12/2018, 31/12/2020, 31/03/2021. Imihla yeengxelo zemali ichazwe yimithetho yobalo. Umhla wamva wengxelo yezezimali Pharma Research Products Co., Ltd yi 31/03/2021. Inzuzo eninzi Pharma Research Products Co., Ltd yinzuzo eyenziwa yinkampani emva kokunciphisa iindleko zokuvelisa nokuthengisa iimveliso zayo kunye / okanye indleko yokubonelela ngeenkonzo zayo. Inzuzo eninzi Pharma Research Products Co., Ltd na 24 557 719 640 ₩
|
|
|
Imihla yeengxelo zezimali Pharma Research Products Co., Ltd
Ingeniso yokusebenza Pharma Research Products Co., Ltd yinkalo yokuphendula eyenza umlinganiselo wenzuzo efunyenwe kwimisebenzi yoshishino, emva kokunciphisa iindleko zokusebenza, ezifana nomvuzo, ukwehla kwexabiso kunye neendleko zeempahla ezithengiswayo. Ingeniso yokusebenza Pharma Research Products Co., Ltd na 12 291 981 680 ₩ Imali engenayo Pharma Research Products Co., Ltd yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo. Imali engenayo Pharma Research Products Co., Ltd na 12 252 962 630 ₩ Iindleko zokusebenza Pharma Research Products Co., Ltd ziindleko ezithatha ishishini ngenxa yokuqhuba imisebenzi yayo yesiqhelo. Iindleko zokusebenza Pharma Research Products Co., Ltd na 22 245 976 410 ₩
|
|
Iimpahla zangoku Pharma Research Products Co., Ltd ziyimpahla yamaphepha ebhalansi ebonisa ukubaluleka kwazo zonke i-asethi ezingatshintshwa zibe yimali emnyakeni owodwa. Iimpahla zangoku Pharma Research Products Co., Ltd na 138 516 283 070 ₩ Imali ekhoyo Pharma Research Products Co., Ltd yimali yonke imali egcinwe yinkampani ngosuku lombiko. Imali ekhoyo Pharma Research Products Co., Ltd na 42 225 410 820 ₩ Ubulungisa Pharma Research Products Co., Ltd bubungakanani bempahla yonke yomnini emva kokususa amatyala onke kwiimpahla ezipheleleyo. Ubulungisa Pharma Research Products Co., Ltd na 262 460 359 910 ₩
|
|
31/03/2021
|
31/12/2020
|
30/09/2020
|
30/06/2020
|
30/09/2019
|
30/06/2019
|
31/03/2019
|
31/12/2018
|
|
|
Inzuzo eninzi
Inzuzo eninzi yinzuzo eyenziwa yinkampani emva kokunciphisa iindleko zokuvelisa nokuthengisa iimveliso zayo kunye / okanye indleko yokubonelela ngeenkonzo zayo.
|
24 557 719 640 ₩ |
21 820 331 150 ₩ |
19 826 387 830 ₩ |
17 866 048 730 ₩ |
11 044 365 080 ₩ |
10 878 456 740 ₩ |
13 000 306 200 ₩ |
9 354 669 590 ₩ |
|
Ixabiso lentengo
Ixabiso lilonke iindleko zemveliso kunye nokuhanjiswa kwemveliso kunye neenkonzo zenkampani.
|
9 980 238 450 ₩ |
9 427 001 150 ₩ |
9 300 146 860 ₩ |
9 830 780 460 ₩ |
8 546 625 910 ₩ |
9 162 555 420 ₩ |
7 455 672 260 ₩ |
7 973 797 470 ₩ |
|
Ingeniso yonke
Imali engenayo ibalwa ngokuphindaphinda ubuninzi beempahla ezithengiswa ngentengo yempahla.
|
34 537 958 090 ₩ |
31 247 332 300 ₩ |
29 126 534 690 ₩ |
27 696 829 190 ₩ |
19 590 990 990 ₩ |
20 041 012 160 ₩ |
20 455 978 460 ₩ |
17 328 467 060 ₩ |
|
Ingeniso yokusebenza
Ingeniso yokusebenza iyimali evela kwingqesho yenkampani. Umzekelo, umthengisi wenza iholo ngenjongo yokuthengiswa kweempahla, kwaye ugqirha uyafumana inzuzo kwiinkonzo zonyango azinikezelayo.
|
- |
- |
- |
- |
19 590 990 990 ₩ |
20 041 012 160 ₩ |
20 455 978 460 ₩ |
17 328 467 060 ₩ |
|
Ingeniso yokusebenza
Ingeniso yokusebenza yinkalo yokuphendula eyenza umlinganiselo wenzuzo efunyenwe kwimisebenzi yoshishino, emva kokunciphisa iindleko zokusebenza, ezifana nomvuzo, ukwehla kwexabiso kunye neendleko zeempahla ezithengiswayo.
|
12 291 981 680 ₩ |
11 347 262 470 ₩ |
9 479 642 560 ₩ |
8 048 454 760 ₩ |
3 625 949 400 ₩ |
4 145 821 810 ₩ |
4 907 524 580 ₩ |
976 194 900 ₩ |
|
Imali engenayo
Imali engenayo yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo.
|
12 252 962 630 ₩ |
10 102 418 350 ₩ |
7 711 393 710 ₩ |
10 085 914 720 ₩ |
3 817 122 310 ₩ |
3 384 805 010 ₩ |
5 134 684 080 ₩ |
6 723 610 190 ₩ |
|
Iindleko zeR & D
Iindleko zophando nophuhliso - iindleko zophando ukuphucula iimveliso kunye neenkqubo okanye ukuphuhlisa iimveliso kunye nemigaqo emitsha.
|
1 928 069 640 ₩ |
1 756 507 560 ₩ |
1 512 250 340 ₩ |
969 849 100 ₩ |
1 224 777 890 ₩ |
1 153 480 760 ₩ |
1 348 601 700 ₩ |
1 096 542 700 ₩ |
|
Iindleko zokusebenza
Iindleko zokusebenza ziindleko ezithatha ishishini ngenxa yokuqhuba imisebenzi yayo yesiqhelo.
|
22 245 976 410 ₩ |
19 900 069 830 ₩ |
19 646 892 130 ₩ |
19 648 374 430 ₩ |
15 965 041 590 ₩ |
15 895 190 350 ₩ |
15 548 453 880 ₩ |
16 352 272 160 ₩ |
|
Iimpahla zangoku
Iimpahla zangoku ziyimpahla yamaphepha ebhalansi ebonisa ukubaluleka kwazo zonke i-asethi ezingatshintshwa zibe yimali emnyakeni owodwa.
|
138 516 283 070 ₩ |
127 403 667 300 ₩ |
119 220 676 550 ₩ |
118 134 950 920 ₩ |
97 794 259 420 ₩ |
101 161 846 340 ₩ |
102 239 680 000 ₩ |
105 768 851 920 ₩ |
|
Ixabiso lilonke
Inani elipheleleyo leempahla lilingana nemali epheleleyo yemali yentlangano, amanqaku amatyala kunye nempahla ebonakalayo.
|
331 490 853 500 ₩ |
319 831 469 290 ₩ |
309 056 125 530 ₩ |
284 785 352 430 ₩ |
264 211 922 060 ₩ |
261 508 698 680 ₩ |
259 017 058 000 ₩ |
258 188 071 760 ₩ |
|
Imali ekhoyo
Imali ekhoyo yimali yonke imali egcinwe yinkampani ngosuku lombiko.
|
42 225 410 820 ₩ |
26 715 006 000 ₩ |
22 592 559 000 ₩ |
42 545 016 510 ₩ |
22 273 508 690 ₩ |
27 134 170 610 ₩ |
23 341 921 000 ₩ |
21 095 733 530 ₩ |
|
Ityala langoku
Ithuba langoku liyinxalenye yetyala elihlawulelwa kunyaka (iinyanga ezili-12) kwaye luboniswe njengemfanelo ekhoyo kunye nenxalenye yemali esebenzayo.
|
- |
- |
- |
- |
16 473 740 910 ₩ |
15 932 665 640 ₩ |
16 439 389 000 ₩ |
15 479 825 760 ₩ |
|
Iyonke imali
Ingqikithi yemali yintlawulo yemali yonke inkampani enayo kwiingxelo zayo, kubandakanywa imali encinci kunye nemali egcinwe ebhankini.
|
- |
- |
- |
- |
- |
- |
- |
- |
|
Ityala elipheleleyo
Iityala ezipheleleyo zidibeneyo zetyala elifutshane kunye nexesha elide. Iimali ezifutshane zesikhashana zizo kufuneka zibuyiselwe ngaphakathi konyaka. Ithuba lexesha elide liquka iimeko zonke ezimele zihlawulwe emva konyaka omnye.
|
- |
- |
- |
- |
38 730 765 930 ₩ |
38 127 205 730 ₩ |
40 156 255 000 ₩ |
39 314 210 750 ₩ |
|
Umlinganiselo weetyala
Ixabiso elipheleleyo lexabiso lemali lilonke lixabiso lemali elibonisa ipesenti yeefayili zeenkampani ezimele njengetyala.
|
- |
- |
- |
- |
14.66 % |
14.58 % |
15.50 % |
15.23 % |
|
Ubulungisa
Ubulungisa bubungakanani bempahla yonke yomnini emva kokususa amatyala onke kwiimpahla ezipheleleyo.
|
262 460 359 910 ₩ |
245 422 802 160 ₩ |
231 187 390 560 ₩ |
223 518 488 530 ₩ |
205 970 563 170 ₩ |
203 262 114 240 ₩ |
198 416 947 000 ₩ |
197 623 416 520 ₩ |
|
Ukuhamba kwemali
Ukuhamba kwemali yintlawulo enemali yemali kunye nokulingana kwemali ejikelezayo kwintlangano.
|
- |
- |
- |
- |
3 732 916 410 ₩ |
6 948 583 500 ₩ |
2 649 629 000 ₩ |
-382 888 580 ₩ |
|
|
Ingxelo yemali yakutshanje kwingeniso ye Pharma Research Products Co., Ltd yayingu-31/03/2021. Ngokweengxelo zamuva malunga neziphumo zezimali ze-Pharma Research Products Co., Ltd, imali engenayo ye-Pharma Research Products Co., Ltd yayingu-34 537 958 090 Laphumelela yaseMzantsi Korea kwaye yaguqulwa ibe yi-+68.84% ngokumalunga nomnyaka odlulileyo. Inzuzo yentlawulo ye Pharma Research Products Co., Ltd kwikota yokugqibela yayingu-12 252 962 630 ₩, inzuzo yentengo ishintshwe ngu-+138.63% xa kuthelekiswa nomnyaka odlulileyo.
|
